# Comparison of Two Solvents Used With Chemotherapy Agent for Transarterial Chemoembolization of Hepatocellular Carcinoma

> **NCT01259414** · PHASE3 · COMPLETED · sponsor: **Sun Yat-sen University** · enrollment: 812 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **OTHER:** Solvent with specific gravity less than lipiodol
- **OTHER:** Solvent with specific gravity equivalent to lipiodol

## Key facts

- **NCT ID:** NCT01259414
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 812 (ESTIMATED)
- **Last updated:** 2019-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01259414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01259414, "Comparison of Two Solvents Used With Chemotherapy Agent for Transarterial Chemoembolization of Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01259414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*